Chembio Diagnostics Return on Investment 2006-2018 | CEMI

Current and historical return on investment (ROI) values for Chembio Diagnostics (CEMI) over the last 10 years.
Chembio Diagnostics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2018-12-31 $-0.01B $0.03B -32.32%
2018-09-30 $-0.01B $0.02B -35.44%
2018-06-30 $-0.01B $0.02B -32.43%
2018-03-31 $-0.01B $0.02B -35.82%
2017-12-31 $-0.01B $0.01B -46.67%
2017-09-30 $-0.01B $0.02B -50.00%
2017-06-30 $-0.01B $0.02B -52.17%
2017-03-31 $-0.01B $0.02B -57.14%
2016-12-31 $-0.01B $0.02B -44.44%
2016-09-30 $-0.01B $0.02B -31.25%
2016-06-30 $-0.00B $0.01B -25.81%
2016-03-31 $-0.00B $0.02B -16.67%
2015-12-31 $-0.00B $0.02B -21.62%
2015-09-30 $-0.00B $0.02B -21.05%
2015-06-30 $-0.00B $0.02B -15.38%
2015-03-31 $-0.00B $0.02B -10.13%
2014-12-31 $-0.00B $0.02B -5.00%
2014-09-30 $0.00B $0.02B 0.00%
2014-06-30 $0.00B $0.02B 5.00%
2014-03-31 $0.00B $0.02B 5.00%
2013-12-31 $0.00B $0.02B 5.41%
2013-09-30 $0.00B $0.02B 11.76%
2013-06-30 $0.00B $0.02B 6.56%
2013-03-31 $0.00B $0.01B 14.55%
2012-12-31 $0.00B $0.01B 22.22%
2012-09-30 $0.00B $0.01B 22.64%
2012-06-30 $0.00B $0.01B 25.53%
2012-03-31 $0.00B $0.01B 20.51%
2011-12-31 $0.00B $0.01B 12.50%
2011-09-30 $0.00B $0.01B 32.00%
2011-06-30 $0.00B $0.01B 36.36%
2011-03-31 $0.00B $0.01B 60.00%
2010-12-31 $0.00B $0.01B 70.59%
2010-09-30 $0.00B $0.00B 28.57%
2010-06-30 $0.00B $0.00B 30.77%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $0.00B $0.00B 0.00%
2009-09-30 $-0.00B $0.00B -36.36%
2009-06-30 $-0.00B $0.00B -36.36%
2009-03-31 $-0.00B $0.00B -36.36%
2008-12-31 $-0.00B $0.00B -61.54%
2008-09-30 $-0.00B $0.00B -57.14%
2008-06-30 $-0.00B $0.00B -80.00%
2008-03-31 $-0.00B $0.00B -94.12%
2007-12-31 $-0.00B $0.00B -88.89%
2007-09-30 $-0.00B $0.00B -80.00%
2007-06-30 $-0.00B $0.01B -88.89%
2007-03-31 $-0.00B $0.01B -123.08%
2006-12-31 $-0.00B $0.01B -177.78%
2006-09-30 $-0.00B $0.00B -400.00%
2006-06-30 $-0.00B $0.00B -400.00%
2006-03-31 $-0.00B $0.00B -228.57%
2005-12-31 $-0.00B $0.00B -160.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.124B $0.033B
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $128.012B 24.96
Medtronic (MDT) Ireland $113.636B 16.61
Stryker (SYK) United States $67.248B 24.66
Boston Scientific (BSX) United States $48.542B 23.59
Baxter (BAX) United States $38.022B 24.39
Zimmer Biomet Holdings (ZBH) United States $24.486B 15.67
Smith & Nephew SNATS (SNN) United Kingdom $16.790B 0.00
Canopy Growth (CGC) Canada $14.340B 0.00
ResMed (RMD) United States $13.953B 26.46
Aurora Cannabis (ACB) Canada $9.078B 64.00
Bio-Rad Laboratories (BIO) United States $8.696B 49.88
Perrigo (PRGO) Ireland $6.775B 10.98
Hill-Rom Holdings (HRC) United States $6.356B 19.66
Insulet (PODD) United States $4.935B 1654.40
GW Pharmaceuticals (GWPH) United Kingdom $4.697B 0.00
ICU Medical (ICUI) United States $4.641B 28.74
Haemonetics (HAE) United States $4.169B 36.99
Hutchison China MediTech (HCM) China $4.067B 0.00
Agios Pharmaceuticals (AGIO) United States $3.290B 0.00
Neogen (NEOG) United States $2.877B 46.77
NuVasive (NUVA) United States $2.794B 24.27
Quidel (QDEL) United States $2.380B 21.30
National Vision Holdings (EYE) United States $2.239B 44.05
Aphria (APHA) $1.960B 0.00
HEXO (HEXO) $1.401B 0.00
Phibro Animal Health (PAHC) United States $1.345B 19.33
VAREX IMAGING (VREX) United States $1.192B 23.34
Cardiovascular Systems (CSII) United States $1.182B 848.25
AtriCure (ATRC) United States $1.052B 0.00
Omeros (OMER) United States $0.928B 0.00
Lantheus Holdings (LNTH) United States $0.921B 24.90
PetIQ (PETQ) United States $0.851B 24.36
MacroGenics (MGNX) United States $0.798B 0.00
Cerus (CERS) United States $0.794B 0.00
NanoString Technologies (NSTG) United States $0.741B 0.00
TG Therapeutics (TGTX) United States $0.716B 0.00
Evolus (EOLS) United States $0.659B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.656B 22.33
OraSure Technologies (OSUR) United States $0.593B 25.81
Surmodics (SRDX) United States $0.543B 79.00
LeMaitre Vascular (LMAT) United States $0.532B 25.29
Meridian Bioscience (VIVO) United States $0.531B 15.81
Quanterix (QTRX) United States $0.478B 0.00
Insys Therapeutics (INSY) United States $0.320B 0.00
Utah Medical Products (UTMD) United States $0.316B 20.57
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.309B 0.00
BioLife Solutions (BLFS) United States $0.308B 126.92
Vapotherm (VAPO) United States $0.289B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Owens & Minor (OMI) United States $0.228B 3.12
Cytosorbents (CTSO) United States $0.224B 0.00
Zynex (ZYXI) United States $0.171B 18.28
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.125B 0.00
Fonar (FONR) United States $0.123B 6.60
Surface Oncology (SURF) United States $0.111B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
United-Guardian (UG) United States $0.086B 19.81
Female Health (VERU) United States $0.081B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Neurotrope (NTRP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 20.34
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.033B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.021B 0.00
Myomo (MYO) United States $0.020B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.03